½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1575372

¼¼°èÀÇ ESR Æ©ºê ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚ, Á¦Ç° À¯Çü, Àç·á, ±â¼ú, ¿ëµµº° ¿¹Ãø(2025-2030³â)

ESR Tubes Market by End User (Diagnostic Laboratories, Hospitals, Research & Academic Institutes), Product Type (Conventional ESR Tubes, Vacuum ESR Tubes), Material, Technology, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 190 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ESR Æ©ºê ½ÃÀåÀº 2023³â¿¡ 1¾ï 2,653¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 1¾ï 3,353¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.84%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 2¾ï 1,472¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ESR(ÀûÇ÷±¸ ħ°­ ¼Óµµ) Æ©ºê´Â Ç÷¾×Çп¡¼­ ÇʼöÀûÀÎ µµ±¸ÀÌ¸ç ½ÅüÀÇ ¿°Áõ ¼öÁØÀ» °áÁ¤ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ESR Æ©ºêÀÇ Çʿ伺Àº ¿°ÁõÀÌ Áß¿äÇÑ Áõ»óÀÎ °¨¿°Áõ, ÀÚ°¡¸é¿ª Áúȯ, ¾Ï µîÀÇ Áø´Ü¿¡ÀÇ ÀÀ¿ë¿¡ ÀÖ½À´Ï´Ù. ÀÌ Æ©ºê´Â ÁÖ·Î º´¿ø, Áø´Ü ½ÇÇè½Ç, ¿¬±¸ ±â°ü¿¡¼­ »ç¿ëµË´Ï´Ù. ESR Æ©ºê ½ÃÀå ¹üÀ§´Â ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, Áúº´ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¼¼°è ÀÇ·á ÀÎÇÁ¶óÀÇ Áøº¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº ½ÇÇè½Ç ÀÚµ¿È­ÀÇ ±â¼ú Çõ½Å°ú ºó¹øÇÑ Ç÷¾× Å×½ºÆ®°¡ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡·Î À̾îÁö´Â ³ëÀεéÀÇ È®´ëÀÔ´Ï´Ù. ÁÖ¿ä ¼ºÀå ±âȸ´Â ÀÇ·á ½ÃÀåÀÌ ±Þ¼ºÀåÇÏ°í ÀÖ´Â ½ÅÈï °æÁ¦ ±¹°¡µé·ÎºÎÅÍ ¼ö¿ä ±ÞÁõ¿¡ ´ëÀÀÇϱ⠶§¹®¿¡ º¸´Ù ½Å¼ÓÇÑ °á°ú¸¦ Á¦°øÇÏ´Â ºñ¿ë È¿À²ÀûÀÎ °í°¨µµ°üÀÇ °³¹ß¿¡ ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä±¸ »çÇ× ¹× Ç°Áú ¹®Á¦·Î ÀÎÇÑ Á¦Ç° ȸ¼ö °¡´É¼º°ú °°Àº ¹®Á¦´Â ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í°¨µµ CRP(hs-CRP) ½ÃÇè°ú °°Àº ´ëü ½ÃÇè ¹æ¹ý°úÀÇ °æÀïµµ À§ÇùÀÌ µÇ°í ÀÖ½À´Ï´Ù. Çõ½Å ±âȸ´Â ³»±¸¼º°ú Á¤È®¼ºÀ» Çâ»ó½ÃÅ°±â À§ÇØ Æ©ºê Àç·á¸¦ °­È­ÇÏ°í, ´õ ³ªÀº µ¥ÀÌÅÍ °ü¸®¸¦ À§ÇÑ µðÁöÅÐ ±â¼ú ÅëÇÕ, Áö¼Ó°¡´É¼º ¸ñÇ¥¿¡ ¸Â´Â ȯ°æ ģȭÀû ÀÎ »ýºÐÇØ ¼º ¿É¼Ç °³¹ß µî¿¡¼­ ãÀ» ¼ö ÀÖ½À´Ï´Ù. ƯÁ¤ Áúº´¿¡ ƯȭµÈ ESR ½ÃÇèÀ» Á¶»çÇÏ¸é »õ·Î¿î ÀÀ¿ë °¡´É¼ºÀÌ ¿­¸± ¼ö ÀÖ½À´Ï´Ù. ESR Æ©ºê ½ÃÀåÀº °æÀï ½ÃÀåÀ̸ç, ³ëÆ÷ ±â¾÷°ú Çõ½Å¿¡ ÀÇÇÑ Á¦Ç° Â÷º°È­¿¡ ÁÖ·ÂÇÏ´Â ½ÅÈï ±â¾÷ÀÌ È¥ÀçÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñÁî´Ï½º ±âȸ¸¦ È°¿ëÇϱâ À§ÇØ ±â¾÷Àº Á¦Ç° Áøº¸¸¦ À§ÇÑ R&D¿¡ ÅõÀÚÇÏ°í Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ½ÃÀå ÁøÀÔ ¹üÀ§¸¦ È®´ëÇÏ°í °ø±Þ¸Á ¹Îø¼ºÀ» °­È­ÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 1¾ï 2,653¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 1¾ï 3,353¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 2¾ï 1,472¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 7.84%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ESR Æ©ºê ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ESR Æ©ºê ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆľÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ °í·ÉÈ­ÀÇ ÁøÀü¿¡ ÀÇÇÑ °Ç°­ ¸ð´ÏÅ͸µ¿ë ESR Æ©ºêÀÇ ÀÌ¿ë È®´ë
    • °³¹ß µµ»ó Áö¿ª¿¡¼­ÀÇ ÀÇ·á ¼­ºñ½ºÀÇ È®´ë°¡ ESR Æ©ºê ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸°´Ù
    • ÁÖ¿ä ±â¾÷¿¡ ÀÇÇÑ ¼±ÁøÀûÀÎ ESR Æ©ºêÀÇ ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ÅõÀÚÀÇ ¹ßÀü
    • ESR Æ©ºê ½ÃÀåÀ» °ßÀÎÇÏ´Â Àúħ½À Áø´Ü¿¡ÀÇ ±âÈ£ÀÇ °íÁ¶
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ESR Æ©ºê ±â¼úÀÇ ÀÎÁöµµ¿Í º¸±ÞÀÌ ¹Ì¹ß´Þ, ½ÅÈï±¹ Áö¿ª¿¡ ÇÑÁ¤µÇ¾î ÀÖ´Â °ÍÀÌ ½ÃÀå È®´ë¿¡ ¿µÇâ
    • ´ëü Áø´Ü ±â¼úÀ̳ª ±â¼ú°úÀÇ °Ý·ÄÇÑ °æÀïÀÌ ESR Æ©ºê ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ Á¦ÇÑ
  • ½ÃÀå ±âȸ
    • µ¿¹°ÀǷḦ °­È­Çϱâ À§ÇÑ µ¿¹° Áø´Ü¿¡ À־ÀÇ ESR Æ©ºêÀÇ ÀÌ¿ë Áõ°¡
    • ½ÇÇè½Ç ½ÃÇèÀÇ Á¤È®¼º°ú È¿À²À» Çâ»ó½ÃÅ°±â À§ÇÑ ESR Æ©ºêÀÇ ±â¼úÀû Áøº¸
    • Æ´»õ ÀÇ·á ¿ëµµ¿¡ ƯȭµÈ ESR Æ©ºê¸¦ Çõ½ÅÇϱâ À§ÇÑ ¹ÙÀÌ¿À Å×Å©³î·ÎÁö ±â¾÷°úÀÇ Äݶ󺸷¹À̼Ç
  • ½ÃÀåÀÇ °úÁ¦
    • ESR Æ©ºêÀÇ °¡°Ý ¼³Á¤°ú »ý»ê¿¡ À־ÀÇ ¿øÀç·áºñ »ó½ÂÀÇ ¿µÇâ
    • ESR Æ©ºê ºÎ¹®¿¡ ½Å±Ô Âü°¡ÀÚ ½ÃÀå ħÅõ¿Í È®´ëÀÇ ¾î·Á¿ò

Porter's Five Forces : ESR Æ©ºê ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ESR Æ©ºê ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¹ýÀ» ¼³¸íÇÕ´Ï´Ù. K´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÇÇÇÒ ¼ö ÀÖÀ¸¸ç ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ESR Æ©ºê ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆľÇ

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ESR Æ©ºê ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¸¦ Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹ÃøÇÒ ¼ö ÀÖ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾ú½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ESR Æ©ºê ½ÃÀå °æÀï ±¸µµ ÆľÇ

ESR Æ©ºê ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ¼¼ºÐÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ESR Æ©ºê ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ESR Æ©ºê ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®ÇÏ°í Á¤È®ÇÏ°Ô ºÎ¹®È­ÇÏ°í Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆľÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ESR Æ©ºê ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

ESR Æ©ºê ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆľÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ È°¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ¸¶·ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆľÇÇÏ°í, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D È°µ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡µµ ´äº¯ÇÏ°í ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °í·ÉÈ­°¡ ÁøÇàµÇ´Â ¼¼°èÀû Àα¸ Áõ°¡¿¡ ÀÇÇØ °Ç°­ ¸ð´ÏÅ͸µ¿¡ À־ÀÇ ESR Æ©ºêÀÇ ÀÌ¿ëÀÌ ³ô¾ÆÁö°í ÀÖ´Ù
      • °³¹ß µµ»ó Áö¿ª¿¡¼­ÀÇ ÀÇ·á ¼­ºñ½ºÀÇ È®´ë¿¡ ÀÇÇØ ESR Æ©ºê ¼ö¿ä°¡ Áõ°¡
      • ¼±ÁøÀûÀÎ ¿¬±¸°³¹ß¿¡ ÁÖ¿ä ±â¾÷¿¡ ÀÇÇÑ ÅõÀÚ Áõ°¡ ESR Æ©ºê
      • Àúħ½À Áø´Ü¹ýÀÇ È£°¨µµ°¡ ³ô¾ÆÁ® ESR Æ©ºê ½ÃÀåÀ» °ßÀÎ
    • ¾ïÁ¦¿äÀÎ
      • °³¹ßµµ»óÁö¿ª°ú °³¹ßµµ»óÁö¿ª¿¡¼­´Â ESR°ü ±â¼úÀÇ ÀÎÁöµµ¿Í ä¿ëÀÌ ÇÑÁ¤µÇ¾î ÀÖ¾î ½ÃÀå È®´ë¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ´Ù
      • ´ëü Áø´Ü ±â¼ú°ú ¼ºÀå ±âȸ¿ÍÀÇ °Ý·ÄÇÑ °æÀïÀ¸·Î ESR Æ©ºê ½ÃÀå
    • ±âȸ
      • µ¿¹°ÀÇ °Ç°­ °ü¸®¸¦ °­È­Çϱâ À§ÇØ ¼öÀÇ Áø´Ü¿¡¼­ ESR Æ©ºêÀÇ »ç¿ëÀ» Áõ°¡
      • ½ÇÇè½Ç Å×½ºÆ®ÀÇ Á¤È®¼º°ú È¿À²À» Çâ»ó½ÃÅ°´Â ESR Æ©ºêÀÇ ±â¼úÀû Áøº¸
      • Æ´»õ ÀÇ·á ¿ëµµ¿¡ ƯȭµÈ ESR Æ©ºê¸¦ Çõ½ÅÇϱâ À§ÇÑ ¹ÙÀÌ¿À Å×Å©³î·ÎÁö ±â¾÷°úÀÇ Äݶ󺸷¹À̼Ç
    • °úÁ¦
      • ¿øÀç·áºñ »ó½ÂÀÌ ½ÃÀå¿¡¼­ ESR Æ©ºêÀÇ °¡°Ý¼³Á¤°ú »ý»ê¿¡ ¹ÌÄ¡´Â ¿µÇâ
      • ESR Æ©ºê ¼½ÅÍ¿¡ ½Å±Ô Âü°¡ÀÚ¿¡°Ô ½ÃÀå ħÅõ¿Í È®´ëÀÇ ¾î·Á¿ò
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ESR Æ©ºê ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • Áø´Ü ½ÇÇè½Ç
  • º´¿ø
    • »ç¸³º´¿ø
    • °ø¸³º´¿ø
  • ¿¬±¸ ¹× Çмú±â°ü

Á¦7Àå ESR Æ©ºê ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¼Ò°³
  • ±âÁ¸ ESR Æ©ºê
  • Áø°øÇü ESR Æ©ºê

Á¦8Àå ESR Æ©ºê ½ÃÀå : Àç·áº°

  • ¼Ò°³
  • À¯¸®
  • Çöó½ºÆ½

Á¦9Àå ESR Æ©ºê ½ÃÀå : ±â¼úº°

  • ¼Ò°³
  • ÀÚµ¿
  • ¼öµ¿

Á¦10Àå ESR Æ©ºê ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • ÀÓ»ó½ÃÇè
  • ¿¬±¸ ¿ëµµ

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ ESR Æ©ºê ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîƼ³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ESR Æ©ºê ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ESR Æ©ºê ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍÅ°
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È
BJH 24.11.07

The ESR Tubes Market was valued at USD 126.53 million in 2023, expected to reach USD 133.53 million in 2024, and is projected to grow at a CAGR of 7.84%, to USD 214.72 million by 2030.

ESR (Erythrocyte Sedimentation Rate) tubes are essential tools in hematology, serving a crucial role in determining inflammation levels in the body. The necessity for ESR tubes lies in their application in diagnosing conditions like infections, autoimmune diseases, and cancer, where inflammation is a key symptom. These tubes are predominantly used in hospitals, diagnostic labs, and research institutions. The market scope for ESR tubes is broadening due to the increasing prevalence of chronic diseases, rising demand for early disease detection, and advancements in healthcare infrastructure globally. Growth is largely driven by technological innovations in laboratory automation and the expanding geriatric population, which leads to a higher incidence of chronic diseases requiring frequent blood tests. A key growth opportunity lies in developing cost-effective, highly sensitive tubes that provide faster results to meet the surge in demand from emerging economies with burgeoning healthcare markets. However, challenges such as stringent regulatory requirements and the potential for product recall due to quality issues can hamper market growth. Additionally, competition from alternative testing methods, like high-sensitivity C-reactive protein (hs-CRP) tests, poses a threat. Innovation opportunities can be found in enhancing tube materials for improved durability and accuracy, integrating digital technologies for better data management, and developing eco-friendly and biodegradable options to align with sustainability goals. Research into specialized ESR tests for specific diseases could unlock new potential applications. The nature of the ESR tube market is competitive, with a mix of well-established players and emerging companies focusing on product differentiation through innovation. To capitalize on these opportunities, businesses should invest in R&D for product advancements and forge strategic partnerships to expand their market reach and reinforce their supply chain agility.

KEY MARKET STATISTICS
Base Year [2023] USD 126.53 million
Estimated Year [2024] USD 133.53 million
Forecast Year [2030] USD 214.72 million
CAGR (%) 7.84%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving ESR Tubes Market

The ESR Tubes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Escalating global aging population contributing to the heightened utilization of ESR tubes for health monitoring
    • Expansion of healthcare services in developing regions boosting the demand for ESR tubes
    • Growing investments by key players in research and development of advanced ESR tubes
    • Increased preference for minimally invasive diagnostic procedures driving the market for ESR tubes
  • Market Restraints
    • Limited awareness and adoption of ESR tube technology in underdeveloped and developing regions impacts market expansion
    • Intense competition from alternative diagnostic techniques and technologies restricts growth opportunities in the ESR tubes market
  • Market Opportunities
    • Increasing utilization of esr tubes in veterinary diagnostics to enhance animal health care
    • Technological advancements in esr tubes for improved accuracy and efficiency in laboratory tests
    • Collaboration with biotechnology firms to innovate specialized esr tubes for niche medical applications
  • Market Challenges
    • The effect of increasing raw material costs on the pricing and production of ESR tubes in the market
    • Difficulty in market penetration and expansion for new entrants in the ESR tubes sector

Porter's Five Forces: A Strategic Tool for Navigating the ESR Tubes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the ESR Tubes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the ESR Tubes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the ESR Tubes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the ESR Tubes Market

A detailed market share analysis in the ESR Tubes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the ESR Tubes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the ESR Tubes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the ESR Tubes Market

A strategic analysis of the ESR Tubes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the ESR Tubes Market, highlighting leading vendors and their innovative profiles. These include AB Medical, Inc., AdvaCare Pharma, BD (Becton, Dickinson and Company), Bio-X Diagnostics, Cardinal Health, Chengdu Rich Science Industry Co., Ltd., CML Biotech Pvt. Ltd., Deltalab, ELITechGroup, FL Medical, Greiner Bio-One International GmbH, Haining Jingteng Rubber Co., Ltd., Improve Medical Instruments Co., Ltd., Kangjian Medical, Kima, Labstac Ltd., PLASTI LAB, SARS SARS SpA, Sarstedt AG & Co. KG, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the ESR Tubes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on End User, market is studied across Diagnostic Laboratories, Hospitals, and Research & Academic Institutes. The Hospitals is further studied across Private Hospitals and Public Hospitals.
  • Based on Product Type, market is studied across Conventional ESR Tubes and Vacuum ESR Tubes.
  • Based on Material, market is studied across Glass ESR Tubes and Plastic ESR Tubes.
  • Based on Technology, market is studied across Automated and Manual.
  • Based on Application, market is studied across Clinical Tests and Research Applications.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Escalating global aging population contributing to the heightened utilization of ESR tubes for health monitoring
      • 5.1.1.2. Expansion of healthcare services in developing regions boosting the demand for ESR tubes
      • 5.1.1.3. Growing investments by key players in research and development of advanced ESR tubes
      • 5.1.1.4. Increased preference for minimally invasive diagnostic procedures driving the market for ESR tubes
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and adoption of ESR tube technology in underdeveloped and developing regions impacts market expansion
      • 5.1.2.2. Intense competition from alternative diagnostic techniques and technologies restricts growth opportunities in the ESR tubes market
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing utilization of esr tubes in veterinary diagnostics to enhance animal health care
      • 5.1.3.2. Technological advancements in esr tubes for improved accuracy and efficiency in laboratory tests
      • 5.1.3.3. Collaboration with biotechnology firms to innovate specialized esr tubes for niche medical applications
    • 5.1.4. Challenges
      • 5.1.4.1. The effect of increasing raw material costs on the pricing and production of ESR tubes in the market
      • 5.1.4.2. Difficulty in market penetration and expansion for new entrants in the ESR tubes sector
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. ESR Tubes Market, by End User

  • 6.1. Introduction
  • 6.2. Diagnostic Laboratories
  • 6.3. Hospitals
    • 6.3.1. Private Hospitals
    • 6.3.2. Public Hospitals
  • 6.4. Research & Academic Institutes

7. ESR Tubes Market, by Product Type

  • 7.1. Introduction
  • 7.2. Conventional ESR Tubes
  • 7.3. Vacuum ESR Tubes

8. ESR Tubes Market, by Material

  • 8.1. Introduction
  • 8.2. Glass ESR Tubes
  • 8.3. Plastic ESR Tubes

9. ESR Tubes Market, by Technology

  • 9.1. Introduction
  • 9.2. Automated
  • 9.3. Manual

10. ESR Tubes Market, by Application

  • 10.1. Introduction
  • 10.2. Clinical Tests
  • 10.3. Research Applications

11. Americas ESR Tubes Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific ESR Tubes Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa ESR Tubes Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AB Medical, Inc.
  • 2. AdvaCare Pharma
  • 3. BD (Becton, Dickinson and Company)
  • 4. Bio-X Diagnostics
  • 5. Cardinal Health
  • 6. Chengdu Rich Science Industry Co., Ltd.
  • 7. CML Biotech Pvt. Ltd.
  • 8. Deltalab
  • 9. ELITechGroup
  • 10. FL Medical
  • 11. Greiner Bio-One International GmbH
  • 12. Haining Jingteng Rubber Co., Ltd.
  • 13. Improve Medical Instruments Co., Ltd.
  • 14. Kangjian Medical
  • 15. Kima
  • 16. Labstac Ltd.
  • 17. PLASTI LAB
  • 18. SARS SARS SpA
  • 19. Sarstedt AG & Co. KG
  • 20. Terumo Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦